CN100525793C - 一种治疗妇科疾病的软胶囊及其制备方法 - Google Patents
一种治疗妇科疾病的软胶囊及其制备方法 Download PDFInfo
- Publication number
- CN100525793C CN100525793C CNB2005100902904A CN200510090290A CN100525793C CN 100525793 C CN100525793 C CN 100525793C CN B2005100902904 A CNB2005100902904 A CN B2005100902904A CN 200510090290 A CN200510090290 A CN 200510090290A CN 100525793 C CN100525793 C CN 100525793C
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- herba
- extract
- oil
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims description 7
- 239000000284 extract Substances 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 17
- 239000007766 cera flava Substances 0.000 claims description 16
- 239000006071 cream Substances 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 15
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 14
- 235000010445 lecithin Nutrition 0.000 claims description 14
- 239000000787 lecithin Substances 0.000 claims description 14
- 229940067606 lecithin Drugs 0.000 claims description 14
- 239000000725 suspension Substances 0.000 claims description 14
- 235000019482 Palm oil Nutrition 0.000 claims description 12
- 238000005516 engineering process Methods 0.000 claims description 12
- 239000002540 palm oil Substances 0.000 claims description 12
- 150000003904 phospholipids Chemical class 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000000375 suspending agent Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000003921 oil Substances 0.000 claims description 9
- 235000019198 oils Nutrition 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 241000722118 Thlaspi Species 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 239000003760 tallow Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000001993 wax Substances 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 claims description 2
- 235000019489 Almond oil Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 241000238631 Hexapoda Species 0.000 claims description 2
- 244000173166 Pyrus ussuriensis Species 0.000 claims description 2
- 235000011572 Pyrus ussuriensis Nutrition 0.000 claims description 2
- 240000000111 Saccharum officinarum Species 0.000 claims description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 2
- 239000008168 almond oil Substances 0.000 claims description 2
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 235000019384 rice bran wax Nutrition 0.000 claims description 2
- 239000004170 rice bran wax Substances 0.000 claims description 2
- 229940084106 spermaceti Drugs 0.000 claims description 2
- 239000012177 spermaceti Substances 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims 2
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 claims 2
- 241001528553 Malus asiatica Species 0.000 abstract description 12
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 2
- 210000001215 vagina Anatomy 0.000 abstract description 2
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 13
- 239000012567 medical material Substances 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000005984 hydrogenation reaction Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 238000010298 pulverizing process Methods 0.000 description 5
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000008347 soybean phospholipid Substances 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- -1 pulverize together Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
Abstract
Description
试验号 | 试验制备工艺 | 放置后的助悬效果 |
1 | 将粉碎后的提取物与油性基质、磷脂简单混合 | 放置分层,粘壁 |
2 | 先将磷脂与粉碎后的提取物简单混合,再与油性基质混合 | 放置未分层,粘壁 |
3 | 将磷脂与提取物混合,一起粉碎,再与油性基质混合 | 放置未分层,不粘壁 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100902904A CN100525793C (zh) | 2005-08-12 | 2005-08-12 | 一种治疗妇科疾病的软胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100902904A CN100525793C (zh) | 2005-08-12 | 2005-08-12 | 一种治疗妇科疾病的软胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1730011A CN1730011A (zh) | 2006-02-08 |
CN100525793C true CN100525793C (zh) | 2009-08-12 |
Family
ID=35962457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100902904A Active CN100525793C (zh) | 2005-08-12 | 2005-08-12 | 一种治疗妇科疾病的软胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100525793C (zh) |
-
2005
- 2005-08-12 CN CNB2005100902904A patent/CN100525793C/zh active Active
Non-Patent Citations (2)
Title |
---|
国家药品监督管理局-国家中成药标准汇编(中成药地方标准上升国家标准部分). 国家药品监督管理局编,315-317. 2002 |
国家药品监督管理局-国家中成药标准汇编(中成药地方标准上升国家标准部分). 国家药品监督管理局编,315-317. 2002 * |
Also Published As
Publication number | Publication date |
---|---|
CN1730011A (zh) | 2006-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106362020B (zh) | 一种具有改善通便作用的松花粉组合物及其制备方法 | |
CN102266452A (zh) | 一种提高缺氧耐受力的中药组合物及其制备方法和应用 | |
CN102988733A (zh) | 治疗产后缺乳的中药组合物及其制备方法 | |
CN100525794C (zh) | 一种治疗鼻炎的软胶囊及其制备方法 | |
CN103230486B (zh) | 一种中药组合物及其制备方法以及在制备治疗脂肪肝药物中的应用 | |
CN104983916A (zh) | 具有增强免疫力及延缓衰老的保健品及其制备方法与应用 | |
CN104524071A (zh) | 一种治疗原发性肾病的药物组合物及其用途 | |
CN100525793C (zh) | 一种治疗妇科疾病的软胶囊及其制备方法 | |
CN100443098C (zh) | 一种治疗妇科疾病的药物 | |
CN113952419B (zh) | 一种用于慢性肾功能衰竭的药物组合物及制备方法和应用 | |
CN108853167A (zh) | 一种含有壳聚糖的痔疮组合物、制备方法及其应用 | |
CN113663023A (zh) | 一种用于治疗高血压的灵芝组合物及其制备方法 | |
CN104225067A (zh) | 用于治疗绝经后骨质疏松的中药组合物、制备方法和用途 | |
CN1318054C (zh) | 一种治疗妇科疾病的药物的制备方法 | |
CN1994330B (zh) | 一种动物类中药材的粉碎方法 | |
CN109512884A (zh) | 一种治疗溃疡性结肠炎的组合物及其颗粒剂和制备方法 | |
CN107648594A (zh) | 枸橼酸氯米芬胶囊及其制备方法 | |
CN102743499A (zh) | 中草药治疗软组织内伤瘀血和脑出血的药物及其制备方法 | |
CN106620367A (zh) | 一种治疗膀胱结石的中药缓释胶囊及制备方法 | |
CN107158046A (zh) | 一种全灵芝孢子粉去壁微丸 | |
CN100509021C (zh) | 一种治疗老年性关节炎的药物 | |
CN101181346B (zh) | 一种独一味软胶囊及其制备方法 | |
CN1931350B (zh) | 一种治疗肝纤维化的中药组合物及其制备方法 | |
CN100500133C (zh) | 一种提高生物利用度及药效的妇科中药复方制剂和制备方法 | |
CN101618059B (zh) | 一种琉璃草总酚酸的制备方法及其制备药物的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU VANGUARD PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: YAO JUNHUA Effective date: 20120307 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120307 Address after: 226100 Jiangsu Province Haimen Economic Development Zone Dinghai Road No. 688 Patentee after: JIANGSU WANGAO PHARMACEUTICAL CO.,LTD. Address before: 226100 Jiangsu Province Haimen Economic Development Zone Dinghai Road No. 688 Patentee before: Yao Junhua |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 226100 Jiangsu Province Haimen Economic Development Zone Dinghai Road No. 688 Patentee after: Jiangsu Wangao Pharmaceutical Co.,Ltd. Address before: 226100 Jiangsu Province Haimen Economic Development Zone Dinghai Road No. 688 Patentee before: JIANGSU WANGAO PHARMACEUTICAL CO.,LTD. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20201229 Address after: No. 123, Houjiao Road, Jiangning District, Nanjing City, Jiangsu Province, 211100 Patentee after: Jiangsu Wanjun Pharmaceutical Technology Co.,Ltd. Address before: 226100 688, Hai Lu, Haimen Economic Development Zone, Jiangsu Patentee before: Jiangsu Wangao Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: No. 123, Houjiao Road, Jiangning District, Nanjing City, Jiangsu Province, 211100 Patentee after: Jiangsu Jiming Pharmaceutical Co.,Ltd. Country or region after: China Address before: No. 123, Houjiao Road, Jiangning District, Nanjing City, Jiangsu Province, 211100 Patentee before: Jiangsu Wanjun Pharmaceutical Technology Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |